Journal List > Blood Res > v.60 > 1516090212

TOOLS
Abdelkreem: Correspondence: “Association of CD40 gene polymorphisms and immune thrombocytopenic purpura in the adult Egyptian population”
CORRESPONDENCE

Blood Res 2025;60:16.

Published online: 7 March 2025

DOI: https://doi.org/10.1007/s44313-025-00066-6

Correspondence: “Association of CD40 gene polymorphisms and immune thrombocytopenic purpura in the adult Egyptian population”

Elsayed Abdelkreem1, *

1Department of Pediatrics, Faculty of Medicine, Sohag University, Sohag 82524, Egypt

*Correspondence: Elsayed Abdelkreem d.elsayedmohammed@med.sohag.edu.eg

Received 16 August 2024       Accepted 28 February 2025

© The Author(s) 2025

(open-access):

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
To the editor:
We read the paper titled “Association of CD40 gene polymorphisms and immune thrombocytopenic purpura in the adult Egyptian population” published by Ellithy et al. [1], and we would like to explain some of the methodological information provided by the authors, which may impact the interpretation of the reported results.
The authors genotyped the CD40 rs1883832 (NM_001250.6:c.−1 T > C) polymorphism in the participants using polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP) with NcoI restriction endonuclease. This enzyme identifies the CCATGG sequence and cleaves the two cytosines. The presence of the CD40 rs1883832 T allele alters the sequence to CTATGG, preventing the NcoI enzyme from performing this cut.
The genotyping criteria for CD40 rs1883832 appear to be incorrect according to the methodological information provided by Ellithy et al. [1]. The NcoI cut of the amplified PCR products was reported for the CD40 rs1883832 T allele in the gel electrophoresis pattern. The presence of two electrophoretic bands of 130 bp and 373 bp was described for the TT genotype, whereas the presence of a single 503 bp band was described for the wild-type (CC) genotype. As such, the genotyping findings and allele frequencies of CD40 rs1883832 (−1 T > C) reported by Ellithy et al. [1] appear to be incorrect. Accordingly, the analysis and interpretation of ITP predisposition and the response to treatment in association with the CD40 rs1883832 (−1 T > C) genotype were affected.
Other researchers have genotyped CD40 rs1883832 (−1 T > C) using the PCR–RFLP technique and have consistently demonstrated that the NcoI enzyme digests the amplified DNA fragments containing the C allele. These results were validated via direct sequencing [2, 3, 4–5].
Figure 1 in Ellithy et al. [1] contains an error: the change in the CD40 rs1883832 nucleotide was incorrectly labeled as G > A.
We think that the authors should carefully review their genotyping methods and validate their results considering the above remarks.

Notes

Authors’ contributions

EA conceptualized and wrote this correspondence.

Funding

No funding, grants, or other support was received.

Data availability

No datasets were generated or analysed during the current study.

Declarations

Competing interests

The authors declare no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

1. Ellithy HN, Yousry SM, Abdel-Aal A, Tawadros L, Momen N. Association of CD40 gene polymorphisms and immune thrombocytopenic purpura in the adult Egyptian population. Blood Res. 2022; 57:229–234. DOI: 10.5045/br.2022.2022057. PMID: 35920091. PMCID: 9492531.
2. Shuang C, Dalin L, Weiguang Y, Zhenkun F, Fengyan X, Da P, et al. Avraham HK, editor. Association of CD40 Gene Polymorphisms with Sporadic Breast Cancer in Chinese Han Women of Northeast China. PloS One. 2011; 6:e23762. https://doi.org/10.1371/journal.pone.0023762. DOI: 10.1371/journal.pone.0023762. PMID: 21912605. PMCID: PMC3166053. PMID: 71097692463d4a9f90c2df77eb724fee.
3. Zhou G, Wang Y, Fang Z, Liu R, Wang A, Zhao F, et al. CD40 -1C>T polymorphism and the risk of lung cancer in a Chinese population. Int J Clin Exp Pathol. 2015; 8:15163–15169. PMID: 26823861. PMCID: 4713647.
4. Deng Z-H, Sun M-H, Li Y-S, Luo W, Zhang F-J, Tian J, et al. Single nucleotide polymorphisms in the CD40 gene associate with the disease susceptibility and severity in knee osteoarthritis in the Chinese Han population: a case-control study. BMC Musculoskelet Disord. 2017; 18:115. DOI: 10.1186/s12891-017-1466-8. PMID: 28320398. PMCID: 5360092.
5. Zhang B, Wu T, Song C, Chen M, Li H, Guo R. Association of CD40 −1C/T polymorphism with cerebral infarction susceptibility and its effect on sCD40L in Chinese population. Int Immunopharmacol. 2013; 16:461–465. DOI: 10.1016/j.intimp.2013.04.028. PMID: 23669336.
TOOLS
Similar articles